![Guy MacDonald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Guy MacDonald
Presidente presso
SCYNEXIS, INC.
Patrimonio netto: 66 029 $ in data 31/08/2026
Profilo
Guy MacDonald is currently Chairman at SCYNEXIS, Inc. since 2015.
Former roles include Chairman at F-Star Therapeutics, Inc. (United States) from 2014 to 2015, Director at Tetraphase Pharmaceuticals, Inc. in 2019, Vice President-Anti Infective & Hospital Products at Merck & Co., Inc. in 2003, and Executive Vice President-Operations at Idenix Pharmaceuticals LLC from 2003 to 2008.
Education includes an undergraduate degree from the University of Dundee.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
SCYNEXIS, INC. 0,13% | 26/06/2026 | 12.625 ( 0,13% ) | 66 029 $ | 31/08/2026 |
Posizioni attive di Guy MacDonald
| Società | Posizione | Inizio |
|---|---|---|
| SCYNEXIS, INC. | Presidente | 04/06/2015 |
Precedenti posizioni note di Guy MacDonald
| Società | Posizione | Fine |
|---|---|---|
| TETRAPHASE PHARMACEUTICALS, INC. | Amministratore Delegato | 01/08/2019 |
| SPRING BANK PHARMACEUTICALS, INC. | Presidente | 17/08/2015 |
| IDENIX PHARMACEUTICALS INC | Direttore operativo | 01/01/2008 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2003 |
Formazione di Guy MacDonald
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
92
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
University Of Dundee
 University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
